Genocea Biosciences Inc.

(GNCA) Trade

By |

Profile

Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.

Contact Information

Website: www.genocea.com
Email: ir@genocea.com
Main Phone: +1 617 876-8191
Address: 100 Acorn Park Drive
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 2140

Issuer Information

Exchange: NSD
CEO: William D. Clark
Employees: 52
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.55 $ -0.0137 (-2.42%)
Last Price 0.55 Change $ -0.0137 Change % -2.42 Tick N/A
Bid 0.53 Bid Size 500.00 Ask 0.68 Ask Size 100.00
Open 0.57 High 0.60 Low 0.55 Prev Close 0.57
Last Trade Volume 159,730 52 Wk Hi 1.39 52 Wk Low 0.49
Market Cap 47.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 86,625,975.00 EPS (TTM) -0.73 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 4
Number of Buys 0 3
Number of Sells 0 1
Net Activity 0 162500
Last 10 Buys Shares
William D. Clark 1,000
George Siber 1,000
George Siber 1,000
Eric S. Hoffman 1,000
Jonathan Poole 1,000
William D. Clark 1,000
Eric S. Hoffman 1,000
Jonathan Poole 1,000
William D. Clark 1,000
Stephen J. Hoffman 1,000
Last 10 Sell Shares
Jonathan Poole 1,000
Jonathan Poole 1,000
Jessica Baker Flechtner 1,000
Jessica Baker Flechtner 1,000
Jessica Baker Flechtner 1,000
Jessica Baker Flechtner 1,000
Jessica Baker Flechtner 1,000
Jessica Baker Flechtner 1,000
Jessica Baker Flechtner 1,000
Jessica Baker Flechtner 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 3.6 3.6 3.6 3.6
Standard Deviation 1.34 1.34 1.34 1.34
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.2 1.2 1.2 1.2